Meet Giancarlo Moscol, M.D.
Giancarlo Moscol, M.D.
Department of General Oncology, Division of Cancer Medicine
In the News
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2006 | San Marcos University, San Fernando School of Medicine, Lima, USA, MD, Bachelor of Medicine - Cum Laude |
Postgraduate Training
| 2014-2017 | Clinical Fellowship, Hematology and Medical Oncology, University of Texas Southwestern Medical Center, Dallas, TX |
| 2009-2012 | Clinical Residency, Internal Medicine, Albert Einstein Medical Center - Thomas Jefferson University, Philadelphia, PA |
Board Certifications
| 2017 | Hematology and Medical Oncology |
| 2012 | ABIM Board Certification in Internal Medicine |
| 2009 | ACLS Certification |
Experience & Service
Other Appointments/Responsibilities
Clinical Instructor, Thomas Jefferson University Hospital, Bone Marrow Transplant Unit, Department of Medical Oncology, Philadelphia, PA, 2012 - 2014
Chief Resident, Clinica El Golf Medical Center, Lima, 2007 - 2009
Physician, Santa Rosa Hospital, Rural National Health Service (SERUMS), Department of Internal Medicine, Iquitos, 2006 - 2007
Practice Coordinator, San Marcos University, San Fernando School of Medicine, Lima, 2002 - 2004
Honors & Awards
| 2015 | Best Fellow's Research Award, Texas Society of Clinical Oncology Annual Meeting, Austin, Texas |
| 2005 | Best Intern of the Year, Arzobispo Loayza National Hospital, Lima Peru |
| 2003 | Scholarship Award for Excellence in Academic Performance, Hipolito Unanue Medical Society |
| 2002 | Dean's List, University of San Marcos |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Valga F, Monzon T, Vega-Diaz N, Santana A, Moscol G, Ruiz-Santana S, Rodriguez-Perez JC. Serum Chloride as a Marker of Cardiovascular and All-cause Mortality in Chronic Hemodialysis Patients: 5-Year follow-up study. Nefrologia (Engl Ed) 43 Suppl 2:47-56, 2023. e-Pub 2024. PMID: 38245440.